Search Browse Earnings

Tenaya Therapeutics, Inc. — SlamSEC

Tenaya Therapeutics, Inc.

Nasdaq:TNYA

Biological Products, (No Diagnostic Substances)·SOUTH SAN FRANCISCO, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Tenaya was a leader of the Ahwahnechee people in Yosemite Valley, California.

Revenue

—

Adj. EBITDA

-$107.5M

FY 2025

Net Income

-$111.1M

FY 2025

EPS (Diluted)

-$1.31

FY 2025

Stock Price

$0.85

-4.5%

2026-03-13

52W Range

$0.36 – $2.35

P/E Ratio

-0.7x

Market Cap

$185.0M

Cash

$4.3M

FY 2025

Total Debt

—

Net Cash

$4.3M

Enterprise Value

$180.6M

Debt / EBITDA

0.0x

FY 2025

EV / EBITDA

-1.7x

Employees

—